Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?Article Published on 2023-04-012023-07-11 Journal: British Journal of Haematology [Category] COVID19(2023년), [키워드] Allogeneic COVID-19 Hematopoietic cell transplantation SARS-CoV-2 transplantation vaccination [DOI] 10.1111/bjh.18591 PMC 바로가기
Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant ResearchArticle Published on 2023-03-172024-09-05 Journal: Transplantation and cellular therapy [Category] update2024, [키워드] Bone marrow transplantation Cord blood death Ethnicity graft versus host disease Haploidentical Hematopoietic cell transplantation Infection Peripheral blood race Relapse related donor survival unrelated donor [DOI] 10.1016/j.jtct.2023.03.007 PMC 바로가기 [Article Type] Article
Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)Practice Guideline Published on 2022-12-012023-07-10 Journal: Transplantation and cellular therapy [Category] COVID19(2023년), [키워드] cellular therapy COVID-19 Hematopoietic cell transplantation SARS-CoV-2 [DOI] 10.1016/j.jtct.2022.09.002 PMC 바로가기 [Article Type] Practice Guideline
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies혈액암 환자와 세포 요법을 받는 환자의 COVID-19 치료 및 예방 방법Article Published on 2022-08-182022-09-11 Journal: Blood [Category] SARS, 변종, 임상, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration approach attenuate breakthrough infections Cell Cell therapy cell transplantation cellular therapy circulating circulating SARS-CoV-2 variants Clinical efficacy coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 in patient COVID-19 vaccine COVID-19 vaccines Drug-drug interactions Factors General population HCT Hematologic malignancy Hematopoietic cell transplantation higher risk Host Humoral response increased risk Infection morbidity morbidity and mortality Patient Postexposure Prophylaxis practicality Prevent progression recipient recipients SARS-CoV-2 Selection severe acute respiratory syndrome Coronavirus severe coronavirus disease severe COVID-19 Side effects therapeutic Therapies therapy treat Treatment virus [DOI] 10.1182/blood.2022016089 PMC 바로가기 [Article Type] Article
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation동종 조혈 세포 이식 후 환자에서 SARS-CoV-2 백신 접종에 대한 항체 반응Article Published on 2022-04-012022-09-11 Journal: Transplantation and cellular therapy [Category] COVID19(2023년), SARS, 치료법, [키워드] age Allogeneic Allogeneic hematopoietic cell transplantation Analysis antibody antibody levels Antibody Response Antibody titer Antibody titers approved BNT162b2 Cell cell transplantation chronic GVHD Cohort conditioning regimen conducted Critical disease domain Efficacy examined Factor Graft-versus-host disease group GVHD had no healthy control healthy controls healthy volunteers hematopoietic Hematopoietic cell transplantation highest homogenous humoral immune response IgA IgG IgM immune response immune responses Immunocompromised patients Immunosuppression information intensity Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 nucleocapsid protein pandemic Patient physician reactivity receiving Receptor-binding domain recipient recipients regimen response revaccination S1 and S2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 pandemic SARS-CoV-2 vaccination second dose significantly lower single center spike glycoprotein stratified subunit Switzerland the SARS-CoV-2 the vaccine transplantation Treatment underlying disease vaccination Vaccine waned was performed [DOI] 10.1016/j.jtct.2022.01.019 PMC 바로가기 [Article Type] Article
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection이전 COVID-19 감염 환자에서 조혈 세포 이식이 가능합니다Article Published on 2022-01-012022-09-11 Journal: Transplantation and cellular therapy [Category] SARS, 치료기술, [키워드] Acute lymphoblastic leukemia acute myelogenous leukemia Allogeneic anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody antibody autologous Cell cell transplantation Characteristics chronic myelogenous leukemia Cohort consecutive patient coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 disease COVID-19 infection Descriptive statistics detectable Diagnosis died disease eight Follow-up fungal Graft-versus-host disease HCT Hematologic malignancy hematopoietic Hematopoietic cell transplantation IgG antibodies IgG antibody Infection initial leukemia Lymphoblastic leukemia lymphoid lymphoma Multiple myeloma Myelodysplastic syndrome myelofibrosis myelogenous leukemia Myeloma one patient outcome Patient patients with asymptomatic performed Pneumonia positive progression of disease recurrence remained retained Retrospective analysis SARS CoV SARS CoV-2 SARS Cov-2 antibody seroconversion. selected Seroconversion Seven susceptible symptomatic COVID-19 disease syndrome tested transplantation Treatment were used [DOI] 10.1016/j.jtct.2021.10.004 PMC 바로가기 [Article Type] Article
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsResearch Published on 2021-10-242022-10-29 Journal: Journal of Hematology & Oncology [Category] COVID-19, [키워드] administration Adults affecting Allogeneic Analysis anti-RBD binding antibody binding domain BNT162b2 BNT162b2 mRNA vaccine CD4 Cell chronic chronic GVHD comparable correlated COVID-19 Cytometry cytometry analysis detectable Factor first vaccination Flow follicular GVHD healthy help helper T cell Hematopoietic cell transplantation identify immunization indicated marker memory B cell mRNA vaccination mRNA vaccine multivariate analyses Neutralizing Neutralizing antibody response Patient patients peripheral blood cell plasmacytoid dendritic cells postvaccination predictor RBD recipient reduced Registered response responses Result risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor significantly lower Stem cell transplantation supplementary material Switched B cells T cell T-SNE therapy vaccination Vaccine was performed were assessed wild type [DOI] 10.1186/s13045-021-01190-3 PMC 바로가기 [Article Type] Research
Lack of correlation between the SARS-CoV-2 cycle threshold (C t ) value and clinical outcomes in patients with COVID-19Article Published on 2021-10-012023-06-19 Journal: Journal of medical virology [Category] MERS, SARS, [키워드] COVID-19 Hematopoietic cell transplantation oxygen SARS-CoV-2/Ct value [DOI] 10.1002/jmv.27171 PMC 바로가기
Successful second outpatient autologous hematopoietic cell transplant for relapsed POEMS syndrome in a patient with coexisting HIV, HBV and syphilis infections during the COVID-19 pandemicCase Reports Published on 2021-08-012023-06-13 Journal: Transplant immunology [Category] B형 간염, SARS, [키워드] Autologous transplant daratumumab Hematopoietic cell transplantation HIV Outpatient HCT POEMS syndrome. [DOI] 10.1016/j.trim.2021.101412 [Article Type] Case Reports
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 PatientsOriginal Article Published on 2021-07-292024-09-02 Journal: Journal of Clinical Immunology [Category] 대상포진, [키워드] Autoinflammation bone marrow failure DADA2 Deficiency of adenosine deaminase 2 Hematopoietic cell transplantation immunodeficiency Inborn error of immunity [DOI] 10.1007/s10875-021-01098-0 PMC 바로가기 [Article Type] Original Article